中文別名: |
鹽酸萘法唑酮;2-[3-[4-(3-氯苯基)-1-哌嗪基]丙基]-5-乙基-2,4-二氫-4-(2-苯氧乙基)-3H-1,2,4-三唑-3-酮鹽酸鹽;奈法唑酮鹽酸鹽;2-[3-[4-(3-氯苯基)-1-哌嗪]丙基]-5-乙基-2,4-二氫-4-(2-苯氧乙基)-3H-1,2,4-三氮-3-酮鹽酸鹽;6-[(4-甲基苯基)磺?;鵠-1-芐基-1,6-二氮雜螺[3.3]庚烷;萘法唑酮鹽酸鹽;萘法唑酮鹽酸鹽 USP標準品;萘法唑酮鹽酸鹽( Nefazodone Hydrochloride );鹽酸奈法唑酮;鹽酸奈法唑酮 標準品;氘代鹽酸奈法唑酮-d5;奈法唑酮,鹽酸D5 |
英文別名: |
1-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one hydrochloride;Nefazodone Hydrochloride;2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one,hydrochloride;3H-1,2,4-Triazol-3-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride;Nefazodone Hydrochlo;BMY-13754;MJ-13754-1;Nefazodone HCl;2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl- 2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride;Serzone;Dutonin;Rulivan;Menfazona;Reseril;Nefazodone (hydrochloride);BMY 13754;Nefadar;2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride;Nefazodone hydrochloride [USAN];MJ 13,754-1;27X63J94GR;1-(3-(4-(m-Chlorophen;2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one Hydrochloride;Nefazodone hydrochloride;3H-1,2,4-Triazol-3-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride (9CI);1-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-3-ethyl-4-(2-phenoxyethyl)-4,5-dihydro-1H-1,2,4-triazol-5-one hydrochloride;BMY 13754-1;MJ 13754-1;Serazone;D00819;NCGC00165846-02;NEFAZODONE HYDROCHLORIDE [USP IMPURITY];1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3-ethyl-4-(2-phenoxyethyl)-4,5-dihydro-1H-1,2,4-triazol-5-one hydrochloride;1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta(sup 2)-1,2,4-triazolin-5-one monohydrochloride;NSC 760344;CAS-82752-99-6;Nefazodone hydrochloride- Bio-X;NEFAZODONE HYDROCHLORIDE;DYCKFEBIOUQECE-UHFFFAOYSA-N;HY-B1396;NEFAZODONE HYDROCHLORIDE (USP MONOGRAPH);3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride;CHEMBL1200492;2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one hydrochloride;Nefazodone HCl;Nefazodone hydrochloride [USAN:USP];CCG-100923;82752-99-6;NEFAZODONE HYDROCHLORIDE (USP-RS);NEFAZODONE HYDROCHLORIDE [MI];SR-01000759312;Nefazadone HCl;Nefazodone hydrochloride, United States Pharmacopeia (USP) Reference Standard;NEFAZODONE HYDROCHLORIDE [USP-RS];NEFAZODONE HYDROCHLORIDE (MART.);MLS000759458;DTXSID8046088;Nefazodone hydrochloride, >=98% (HPLC), solid;Nefazodone hydrochloride (USAN:USP);CHEBI:7495;NEFAZODONE HYDROCHLORIDE [ORANGE BOOK];SMR000449297;SR-01000759312-6;Tox21_113574;CS-4860;Nefazodone Hcl;BN164641;Q27107509;MLS000758241;T72976;3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl))propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride;A840427;Nefazodone hydrochloride (USP);EN300-6731074;SCHEMBL41119;KS-1088;MFCD00935760;NSC-760344;Nefazodone Hydrochloride 1.0 mg/ml in Methanol (as free base);2-... |